2Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocelluar carcinoma with hepatitis B and C virus infection [J]. J Gastroenterol Hepatol, 2000,15(4): 4311.
3Shito T,Yoshihama T, Yugari Y. Antitum or composition[J].Brit Pat,1995,87(9) :1978.
4Morse M A, Zhou L J, Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage colony stimulating factor, interlleukin-4 and tumor necrosis factor-alpha for use in cancer immuno therapy[J]. Surgery, 1997,6(1):6.
5Akbar S M,Inaba K,Onji M. Upregulation of MHC class Ⅱantigen on dendritic cells from hapetitis B virus transgenic mice by interferon-gamma:abrogation of immune response defect to a T-cell-dependent antigen[J]. Immunology, 1996,87 (4): 519.
6Shan J J,Wang Y,Wang S C,et al. Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigenpresenting cells that has the capacity to stimulate a specific anti leukaemia cytotoxic T-cell response from patients with chronic myeloid leukaemia[J ]. Br J Haematol, 2000,111 (2): 596.
7Wesa A , Galy A. Increased production of pro-inflammato rycytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand [J]. Immunol,2002, 3 (1): 14.
8Liaw Y F, Leung N, Guan R, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update[J ]. J Gastroenterol Hepatol, 2003,18 (3): 239
